A detailed history of Cx Institutional transactions in Pfizer Inc stock. As of the latest transaction made, Cx Institutional holds 25,655 shares of PFE stock, worth $763,236. This represents 0.03% of its overall portfolio holdings.

Number of Shares
25,655
Previous 50,058 48.75%
Holding current value
$763,236
Previous $1.39 Million 48.38%
% of portfolio
0.03%
Previous 0.07%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$25.26 - $29.6 $616,419 - $722,328
-24,403 Reduced 48.75%
25,655 $717,000
Q1 2024

Apr 15, 2024

SELL
$25.89 - $29.73 $1.55 Million - $1.78 Million
-59,800 Reduced 54.43%
50,058 $1.39 Million
Q4 2023

Jan 12, 2024

BUY
$26.13 - $33.94 $147,033 - $190,980
5,627 Added 5.4%
109,858 $3.16 Million
Q3 2023

Oct 17, 2023

BUY
$32.09 - $37.51 $1.82 Million - $2.13 Million
56,661 Added 119.11%
104,231 $3.46 Million
Q2 2023

Jul 26, 2023

SELL
$36.12 - $41.79 $250,672 - $290,022
-6,940 Reduced 12.73%
47,570 $1.74 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $7,878 - $10,256
-200 Reduced 0.37%
54,510 $2.22 Million
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $419,921 - $548,161
10,058 Added 22.53%
54,710 $2.8 Million
Q3 2022

Nov 04, 2022

SELL
$43.76 - $53.42 $2.46 Million - $3 Million
-56,135 Reduced 55.7%
44,652 $1.95 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $660,586 - $783,248
14,197 Added 16.4%
100,787 $5.28 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $926,803 - $1.15 Million
-20,258 Reduced 18.96%
86,590 $4.48 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $2.99 Million - $4.43 Million
72,378 Added 209.97%
106,848 $6.31 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $1.25 Million - $1.6 Million
-31,788 Reduced 47.98%
34,470 $1.48 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $110,171 - $124,806
3,068 Added 4.86%
66,258 $2.6 Million
Q1 2021

Apr 15, 2021

SELL
$33.49 - $37.77 $1.13 Million - $1.27 Million
-33,678 Reduced 34.77%
63,190 $2.29 Million
Q4 2020

Jan 12, 2021

SELL
$33.47 - $42.56 $443,276 - $563,664
-13,244 Reduced 12.03%
96,868 $3.57 Million
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $2.65 Million - $3.1 Million
83,315 Added 310.91%
110,112 $4.04 Million
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $11,566 - $14,031
-384 Reduced 1.41%
26,797 $876,000
Q1 2020

Apr 29, 2020

BUY
$27.03 - $38.62 $31,219 - $44,606
1,155 Added 4.44%
27,181 $887,000
Q4 2019

Jan 21, 2020

SELL
$32.92 - $37.36 $3,588 - $4,072
-109 Reduced 0.42%
26,026 $1.02 Million
Q3 2019

Oct 10, 2019

BUY
$32.49 - $42.13 $4,126 - $5,350
127 Added 0.49%
26,135 $939,000
Q2 2019

Jul 17, 2019

SELL
$36.98 - $41.52 $109,497 - $122,940
-2,961 Reduced 10.22%
26,008 $1.13 Million
Q1 2019

Apr 03, 2019

BUY
$37.5 - $41.2 $195,637 - $214,940
5,217 Added 21.96%
28,969 $1.23 Million
Q4 2018

Jan 14, 2019

SELL
$38.47 - $43.86 $527,077 - $600,925
-13,701 Reduced 36.58%
23,752 $1.04 Million
Q3 2018

Oct 09, 2018

BUY
$34.47 - $41.81 $48,120 - $58,366
1,396 Added 3.87%
37,453 $1.65 Million
Q2 2018

Jul 12, 2018

BUY
$32.98 - $35.16 $410,073 - $437,179
12,434 Added 52.64%
36,057 $1.31 Million
Q2 2018

Jul 12, 2018

BUY
$32.98 - $35.16 $779,086 - $830,584
23,623 New
23,623 $838,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.